Sun, Jul 20, 2025 | Updated 02:31 IST
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Aug 19, 2020
Hyderabad (Telangana) [India], Aug 19 : Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment...
Odisha government to start favipiravir therapy for COVID-19 patients in home Isolation
Oct 05, 2020
Bhubaneswar (Odisha) [India], October 6 : The Odisha government has decided to start favipiravir therapy for COVID-19 patients getting treatment in home isolation.
COVID-19 crisis: Over 5 lakh Favipiravir Tablets from UAE arrive in India
May 11, 2021
New Delhi [India] May 11, : Amid the unprecedented rise in COVID-19 cases in India, over five lakh Favipiravir Tablets from the UAE reached...
Converge Biotech announces the launch of Vergiflu (Favipiravir 200 mg) in India to treat mild to moderate Covid-19
Aug 04, 2020
Hyderabad (Telangana) [India] Aug 4 (ANI/BusinessWire India): Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet...
India welcomes 15 ventilators, 12000 tablets of Favipiravir from Iceland
Jun 02, 2021
New Delhi [India], June 2 : India on early Wednesday received a consignment of 15 ventilators, and 12000 tablets of Favipiravir from Iceland as...
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Jul 13, 2020
Mumbai (Maharashtra) [India], July 13 : Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand...
Health Ministry issues guidelines for rational use of medicines, tests for COVID-19 patients
Jun 07, 2021
'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir, Favipiravir in fighting COVID-19'
May 15, 2020
Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India
May 12, 2020
Glenmark releases interim data from PMS Study on Favipiravir (FabiFluĀ®)
Jun 09, 2021
Sun Pharma launches Favipiravir in India for Rs 35 per tablet
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFluĀ®)
Sep 15, 2021
Related Videos
No Result Found